Clinical Research Unit

RESEARCH PROTOCOLS (Currently Enrolling):

GLOMERULAR DISEASE

• Anti-hypertensive therapy for Proteinuric kidney disease (Valsartan +/- Aliskiren)
• Focal Segmental Glomerulosclerosis Clinical Trial (cyclosporine vs. MMF/pulse steroids)
• Rituximab in Class III or IV Lupus Nephritis (LUNAR study)
• Genetics of IgA Nephropathy Consent Intake Form (Holly Snyder 84922)

CHRONIC KIDNEY DISEASE

• TEMPO: Tolvaptan in the treatment of Autosomal Dominant Polycystic Kidney Disease
  Cardiovascular Outcomes in Renal Atherosclerotic Lesions (CORAL study):
• Neutrophil Gelatinase-Associated Lipocalin (NGAL) as a marker for progressive decline in kidney function
• Quality of Life Study: Consent EQ5D (eng) KDQOL (eng) EQ5D (sp) KDQOL (sp)

KIDNEY TRANSPLANT

• Relationship Between Biomarkers and Rejections and/or Calcineurin Inhibitor Toxicity
• Efficacy and safety of early calcineurin inhibitor withdrawal in renal transplant recipients maintained on MMF(CellCept) and sirolimus (Rapamune)
  

To enroll in any of these research protocols, please contact one of the above personnel by email or telephone 212-305-8879